It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The current inhabitants of the Canary Islands have a unique genetic makeup in the European diversity landscape due to the existence of African footprints from recent admixture events, especially of North African components (> 20%). The underrepresentation of non-Europeans in genetic studies and the sizable North African ancestry, which is nearly absent from all existing catalogs of worldwide genetic diversity, justify the need to develop CIRdb, a population-specific reference catalog of natural genetic variation in the Canary Islanders. Based on array genotyping of the selected unrelated donors and comparisons against available datasets from European, sub-Saharan, and North African populations, we illustrate the intermediate genetic differentiation of Canary Islanders between Europeans and North Africans and the existence of within-population differences that are likely driven by genetic isolation. Here we describe the overall design and the methods that are being implemented to further develop CIRdb. This resource will help to strengthen the implementation of Precision Medicine in this population by contributing to increase the diversity in genetic studies. Among others, this will translate into improved ability to fine map disease genes and simplify the identification of causal variants and estimate the prevalence of unattended Mendelian diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Instituto Tecnológico y de Energías Renovables (ITER), Genomics Division, Santa Cruz de Tenerife, Spain (GRID:grid.425233.1)
2 Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain (GRID:grid.411331.5) (ISNI:0000 0004 1771 1220)
3 Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain (GRID:grid.411331.5) (ISNI:0000 0004 1771 1220); Instituto de Salud Carlos III, CIBER de Enfermedades Respiratorias, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
4 Área de Medicina Preventiva y Salud Pública, Universidad de La Laguna, Santa Cruz de Tenerife, Spain (GRID:grid.10041.34) (ISNI:0000000121060879)
5 Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain (GRID:grid.411331.5) (ISNI:0000 0004 1771 1220); Área de Medicina Preventiva y Salud Pública, Universidad de La Laguna, Santa Cruz de Tenerife, Spain (GRID:grid.10041.34) (ISNI:0000000121060879)
6 Instituto Tecnológico y de Energías Renovables (ITER), Genomics Division, Santa Cruz de Tenerife, Spain (GRID:grid.425233.1); Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain (GRID:grid.411331.5) (ISNI:0000 0004 1771 1220); Instituto de Salud Carlos III, CIBER de Enfermedades Respiratorias, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universidad Fernando Pessoa Canarias, Facultad de Ciencias de La Salud, Las Palmas de Gran Canaria, Spain (GRID:grid.512367.4)